TSA treatment of pancreatic cancer cells inhibited cell proliferation amd induced cell apoptosis through cell cycle arrest and altered expression of pro-apoptotic gene (BIM) versus anti-apoptotic genes (Bcl-xL and Bcl-W) [34], [47], [48]. The gene discussed is BCL2L1; the disease is pancreatic neoplasm.